Preparation and immunogenic properties of a recombinant West Nile subunit vaccine - Wikidata - awgldk - TriplyDB

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

http://www.wikidata.org/entity/Q27478202

about

Vaccines in development against West Nile virus A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis Antibody Recognition of Cell Surface-Associated NS1 Triggers Fc- Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected Cells Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters Flavitrack analysis of the structure and function of West Nile non-structural proteins West nile virus: characteristics of an african virus adapting to the third millennium world.Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults Current trends in West Nile virus vaccine development.Differentiation of West Nile virus-infected animals from vaccinated animals by competitive ELISA using monoclonal antibodies against non-structural protein 1 Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model.Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.Tick-borne Encephalitis Vaccines.A review of vaccine approaches for West Nile virus.Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.Technologies for the development of West Nile virus vaccines.Optimized expression of the antimicrobial protein Gloverin from Galleria mellonella using stably transformed Drosophila melanogaster S2 cells.Recent advances in the production of recombinant subunit vaccines in Pichia pastoris.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.ELISA and Neutralization Methods to Measure Anti-West Nile Virus Antibody Responses.Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice.Production, quality control, stability, and potency of cGMP-produced RH5.1 protein vaccine expressed in S2 cells West Nile virus A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen

P2860

Q26999702-82C12420-8D4E-48FB-81FA-B3AB4F401501 Q27321020-8B8DC465-D0DB-49C0-83A8-45C1C43F2EFE Q27478158-DF266030-3F63-464D-9B50-56B527093E33 Q27478425-8D2BFB2A-4DB2-4AEE-82A0-0FD1787DEA65 Q27481025-9BB8F98C-E8BD-4E59-9A20-4ED29ACD4FA4 Q27481420-D52748A7-FEB1-4C58-A3A1-15DD1963B254 Q27484980-439E4266-2FCA-44D0-8C1B-C8ECC5BDA419 Q27487992-C276275D-2A20-41F1-AC71-3EAB8A722524 Q27489620-DE78AE81-55CA-4DD2-A7DA-9FA547DFAD26 Q27490208-7F614FC3-C7A7-4154-B58B-490DA34ED52E Q27491325-4B714BBE-76B4-4F5C-A126-798AA711F728 Q30227143-ADEFBAAE-DA38-4839-960A-A1E480A91C64 Q33584872-A0AB54DF-D4EB-4461-955A-F5DA54166BEF Q34154300-07DE0C22-2476-4071-A3CA-3A769ABD0122 Q34788758-6D6446B9-11DB-461E-8B1B-C678BF8501A0 Q35964842-3F79B187-BC1F-4B74-8378-FE948E829CBE Q36156558-3B70FEE5-1ACF-44A6-BE48-60B785656FCF Q36780133-4F7E00E3-CD02-4716-84B0-1D4876843294 Q37120117-F7EF7810-A4F3-4909-ACC6-DB5A7DDCF16E Q37127083-2CB1C8DD-E378-40EC-998E-7892CB6CD894 Q37236968-A9F94687-E31F-47D2-AB75-6958633E8AE9 Q37842337-C308C680-01FC-43C3-BE92-8AA8FBE18BB6 Q38269151-E4CA3947-5673-44B2-B2D4-E2F66587DDD1 Q38718931-3322B2FA-7566-4BDB-94EC-4C6A9B8C5296 Q38849581-94C0D05B-0A52-4E15-9E9C-F00FACE7DB75 Q38866173-92A7365D-F14C-4C84-86EE-CCBFBB9C4D9B Q40671274-616ECAE7-8E37-4846-A064-05306E3BA9CB Q47550067-85A943EB-CD6B-4EA6-B574-55FAA15A5E10 Q56342201-889790A5-21A3-4151-9E85-F3C9A3AFBD5A Q56932479-3072888B-6C9B-4820-B798-EBBBF9AF0398 Q57299898-2B7A97B1-CD54-45C5-A19F-E2FB172A3767

P2860

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

http://www.wikidata.org/entity/Q27478202

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

@ast

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

@en

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

@nl

type

label

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

@ast

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

@en

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

@nl

prefLabel

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

@ast

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

@en

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

@nl

P1433

Q27478202-42503ECF-6D3D-4EE0-9329-385917FE8F3A

P1476

Q27478202-E2DDA6FD-C056-4801-BB3C-E25845189E6A

P2093

Q27478202-0742595D-DB5D-4F88-8782-B091AC349113

Q27478202-16243073-5464-4610-B7F4-D929460C45E4

Q27478202-1629CF0C-9A5A-4B64-B730-08CCABD2D641

Q27478202-2DEA4D87-A96B-4757-AB8C-8E1C470C181B

Q27478202-53213BA9-C83E-48C8-9979-EABFD7147965

Q27478202-646A51F1-A3E6-48FF-953E-E86B9627BB34

Q27478202-77E70123-E022-4B48-840F-616354803D45

Q27478202-AAA0C629-0DB7-445F-8839-860AB1C46AE6

Q27478202-C86DCE71-6661-4DD0-BFB8-AFB59398E71A

Q27478202-D507C685-CAF1-4D14-B373-9CAEF0B2C528

P2860

Q27478202-08820C7C-9610-43AC-8B7E-7DF4E3B0D4C5

Q27478202-10DB64F4-1713-4058-A209-A3119292A30D

Q27478202-13117E8A-732D-4865-9151-A985CE423477

Q27478202-14B75929-B9FC-46BA-A62B-43F51B552743

Q27478202-163E5F81-7B51-4DE3-BDC1-9752CDEDCB36

Q27478202-18B9EB55-15C9-4EE7-A081-4604D96C2A19

Q27478202-1931B096-0F32-4CD0-8A4A-ACB279F2F1B7

Q27478202-1A429CB3-ABC8-4BDD-921B-046738F62B43

Q27478202-1B0E599E-7BC2-4F15-BDD8-EBB0FBA84790

Q27478202-1B824D8D-4383-4573-A8F2-A7A796978B5D

P304

Q27478202-19D417EC-50C3-4098-B537-458C3C1DA568

P31

Q27478202-27E7CA7F-D69F-490F-BB1D-0972AFFBE252

P356

Q27478202-EA642315-8D29-4310-9696-F5BB371D2564

P407

Q27478202-D82123E9-233E-4548-A56A-28D8D61EE5DD

P433

Q27478202-36B1CEB5-9EDC-4C1F-8725-BD7A5118ACAA

P478

Q27478202-241471C4-1A00-4027-BBA0-B7030F9E4E65

P50

Q27478202-6C4E5CAF-34D1-4DEB-A2EA-9F4DFDD086F2

Q27478202-91F97D23-CD81-4A1C-9B84-D9EE72C4B264

Q27478202-9B636E6B-9D7C-4354-98A1-629B72EC6BB1

P577

Q27478202-AF72A206-2666-44CD-8E81-FCC4E9282989

P5875

Q27478202-0FE22200-B8EE-4233-BFC7-D6BF3BFA5ED7

P698

Q27478202-C836199B-89F1-4281-9666-1D6A5F068587

P921

Q27478202-21DB59C2-1D8A-4BBF-B64A-DE4AFE038667

P932

Q27478202-DD88E848-887A-47B0-A77C-2A6A132657DF

P356

J.VACCINE.2006.08.018

P1433

P1476

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

@en

P2093

Beth-Ann Coller

http://www.w3.org/2001/XMLSchema#string

Carolyn Weeks-Levy

http://www.w3.org/2001/XMLSchema#string

David E Clements

http://www.w3.org/2001/XMLSchema#string

Douglas M Watts

http://www.w3.org/2001/XMLSchema#string

Gloria Corpuz

http://www.w3.org/2001/XMLSchema#string

Gordon Wang

http://www.w3.org/2001/XMLSchema#string

Julia Leung

http://www.w3.org/2001/XMLSchema#string

Lynne Gilson

http://www.w3.org/2001/XMLSchema#string

Michael M Lieberman

http://www.w3.org/2001/XMLSchema#string

Steven Ogata

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey

Clinical characteristics of the West Nile fever outbreak, Israel, 2000

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc Receptor-Dependent and -Independent Mechanisms

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites.

A ligand-binding pocket in the dengue virus envelope glycoprotein

Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis

P304

414-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2006.08.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Amélia Paes de Andrade Travassos da Rosa

P577

2007-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6797220

http://www.w3.org/2001/XMLSchema#string

P698

16996661

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

P932

1839850

http://www.w3.org/2001/XMLSchema#string